Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18

Veterinary Immunology and Immunopathology

Volumn 132, Issue 2-4, 2009, Pages 270-274

  Yin, Rong lan ^a   Li, Chang ^b   Yang, Zheng tao ^a   Zhang, Yan jing ^a   Bai, Wen lin ^c   Li, Xiao ^b   Yin, Rong huan ^c   Liu, Hui ^a   Liu, Shan ^a   Yang, Qi ^a   Cao, Yong guo ^a   Zhang, Nai sheng ^a  

^a JILIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SHENYANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

bIL18; ClfA; DNA vaccine; Staphylococcus aureus

Indexed keywords

CLUMPING FACTOR A; DNA VACCINE; FIBRONECTIN BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; DRUG DESIGN; EUKARYOTE; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BASE SEQUENCE; CATTLE; COAGULASE; CYTOKINES; DNA PRIMERS; DNA, BACTERIAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HELA CELLS; HUMANS; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MASTITIS, BOVINE; MICE; MICE, INBRED BALB C; PLASMIDS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TH1 CELLS; TRANSFECTION; VACCINES, DNA;

ANIMALIA; BOVINAE; EUKARYOTA; MUS; STAPHYLOCOCCUS AUREUS;

EID: 70449532372     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.05.012     Document Type: Article

References (10)

1. Brouillette E., Lacasse P., Shkreta L., Belanger J., Grondin G., Diarra M.S., Fournier S., and Talbot B.G. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine 20 (2002) 2348-2357
2. Josefsson E., Hartford O., O'Brien L., Patti J.M., and Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184 (2001) 1572-1580
3. Kerro-Dego O., Prysliak T., Potter A.A., and Perez-Casal J. DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus. Vet. Immunol. Immunopathol. 113 (2006) 125-138
4. Kutzler M.A., and Weiner D.B. DNA vaccines: ready for prime time?. Nat. Rev. Genet. 9 (2008) 776-788
5. Leitner G., Lubashevsky E., and Trainin Z. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model. Vet. Immunol. Immunopathol. 93 (2003) 159-167
6. Middleton J.R. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev. Vaccines 7 (2008) 805-815
7. Mingxiao M., Ningyi J., Zhenguo W., Ruilin W., Dongliang F., Min Z., Gefen Y., Chang L., Leili J., Kuoshi J., and Yingjiu Z. Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 24 (2006) 4304-4311
8. Sambrook D.W.R.J. Molecular cloning: A Laboratory Manual. 3rd ed. (2001), Cold Spring Harbor Laboratory Press, New York
9. Shinefield H.R., and Black S. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev. Vaccines 4 (2005) 669-676
10. Sykes K. Progress in the development of genetic immunization. Expert Rev. Vaccines 7 (2008) 1395-1404